Optibiotix Health Share Discussion Threads

[essential] 23/2/2017 09:19

Agree the RNSs have been hype and no substance. Thought a spin off listing was being mooted?

[scotty1] 23/2/2017 09:18

I still believe we will turn around this area and start to move back up,infact i'll do a diamond and predict we will be back up in the mid to high 70s this time next week,the only difference between mine and diamonds prediction is that mine will be correct ;))

[john henry] 23/2/2017 09:16

Imho and i will email the company,the interviews and hype need to be controlled around market driving news.
The constant pumping of the share price around interviews, presentations etc isnt doing the companies any favours. Their PR certainly needs to be looked into.
Basically if you cant deliver, dont hype.
Unfortunately again today, being sold down early doors.

[scotty1] 23/2/2017 09:12

Well get buying then JH and reverse it ;))must be good for you trading pot around here.

[john henry] 23/2/2017 09:10

The buy sell ratio has got to reverse first scotty, currently around 55K sells and 26K buys.

[judijudi] 23/2/2017 08:52

Scotty,
:)

[scotty1] 23/2/2017 08:20

Imo we are at the point were we will start to attract buyers once more,you know the likes of JH etc which should start and push the share price back up.Then of course they will sell at the 80p mark but hopefully we will have news on the way up which will push us through that 80p barrier once and for all.

[scotty1] 23/2/2017 08:15

Oh dear diamond another prediction failure from your post last Thursday if only you had predicted it would fall every day you would have remained a share guru lol.

diamond fibre - 16 Feb 2017 - 16:53:32 - 19839 of 19958 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI

Tomorrow or next week we will rise. DIAMOND

[rafboy] 23/2/2017 08:14

Sounds like we are getting close to launching skinbiotix.

[joyjoy13] 23/2/2017 02:25

Great find Loungact,
I like the sound of those attending.....

One Nucleus: Leadership Seminar




Rapid advances are being made in our understanding of the microbiome leading to a fundamental shift in the way we understand how microbes can be used to improve human health and wellbeing throughout life.

Microbiome – Research to Revenue is a one day event at Norwich Research Park to bring together the innovation supply chain within the microbiome sector.

The event is part of the One Nucleus Life Science Leadership Series and will highlight the interest in the sector, from the perspective of both major corporates and investors, including potential applications and market opportunities. You will also hear from new startups who will showcase the latest innovative products and services in the sector.

Programme

10:30 - Registration and Coffee

11:00 - The Science of Preventive Healthcare
Professor Ian Charles, Quadram Institute

11:15 - Session 1 – Research Trends and Market Focus

11:15 - Barry Murphy, Unilever
11:35 - Scott Parkinson, Nestle Institute of Health Sciences
Mojgan Masoodi, Nestle Institute of Health Sciences
11:55 - Mike Salter, AB Agri
12.15 - Speaker to be confirmed

12:35 - Lunch and Networking

13:45 - Keynote Address - Rt Hon George Freeman

14:00 - Session 2 – Investors View and Start-Up Showcase

This session will give the opportunity to two investors, Seventure Partners and Arix Bioscience to provide their insights on the microbiome markets and investment trends. It will be followed by three start-ups presentations.

14:00 - Denise Kelly, Seventure Partners

14:20 - Microbiome: Gut Feelings
Jonathan Tobin, Arix Bioscience

14:40 - Stephen France, SkinBiotix

15:00 - Microbiotica – Commercialising Leading Microbiome Science
Mike Romanos, Microbiotica

15:20 - Jackie Hunter, Benevolent

15:40 - Closing Remarks

15:50 - Networking

16.30 - Close


hxxp://www.onenucleus.com/onenucleus-events?id=1074

[loungeact] 23/2/2017 00:30

Skinbiotix start-up presentation. Dr Cath O'Neil is listed down to present on the 2nd March.

"Microbiome – Research to Revenue" is a one day event at Norwich Research Park to bring together the innovation supply chain within the microbiome sector. The event is part of the One Nucleus Life Science Leadership Series and will highlight the interest in the sector, from the perspective of both major corporates and investors, including potential applications and market opportunities. You will also hear from new startups who will showcase the latest innovative products and services in the sector.

hxxp://www.norwichresearchpark.com/newsandevents/events/leadershipseminarmicrobiomeresearchtorevenue.aspx

[elrico] 22/2/2017 22:10

ironmom aka percy - Due to ND I cannot say. However, if you PM I'll send you a secure payment portal where you can deposit....shall we say, a donation, on receipt I'll tell you how much I have been bought for, if you promise not to cough.

wh - always naughty - my wife loves it.

[whl2] 22/2/2017 21:56

He's not the saviour, he's a very naughty boy!

[ironman22] 22/2/2017 20:52

Elrico, saviour of Opti to the rescue. You really do have to counteract any & every slight against Opti don't you. How much are they paying you?

[parob] 22/2/2017 18:19

"There could be a surprising link between how people respond to a new cancer treatment and their microbiome.

Cancer immunotherapy - treatments that harness the body's immune system to fight cancer - has been gaining traction in recent years as a new approach to treating the disease.

But one of its major drawbacks is its variability: For some cancer patients, the drugs have led to remarkable remissions with few side effects. Others have tried them only to find little benefit and a lot of discomfort.

It's something researchers have been trying to understand, exploring whether there are other drugs that could be used to boost the response in some people, or if genetics could be playing an underlying role in making it more effective in others.

And they may finally be onto something. A team of researchers has recently discovered a link between people's responses to immunotherapy treatments and the microbes that live in their gut. Having a more diverse gut microbiome, they found, is linked to a better response.

The research, which will be presented at an upcoming medical conference, is the first study to make this link in people. Previous studies have however found similar results in mice."

------------------

Is this where OPTI's "potential for precision microbiome medicine" could come in useful?

[elrico] 22/2/2017 17:39

Super food's are always on the discount so GoFigure have to natch them.

[judijudi] 22/2/2017 17:34

Are they struggling to sell it?
More special offers than Ponden Mill!

[onedayrodders] 22/2/2017 16:28

Hopefully Christina Wood will start to earn her wages soon.
4 weeks into her role so not that long

and of course Per Rehné .. they haven'r come aboard to sit and do nothing

keep the faith

[essential] 22/2/2017 16:00

Even share profits have stopped promising the "big" announcements...it is a painful wait while the price dribbles lower

[lodger] 22/2/2017 15:41

At least part of the reason why the share price is drifting down must be because of the sells from the estates of private investors that have literally died of boredom.

[joyjoy13] 22/2/2017 10:11

Wonder if these were the guys selling to release funds for their new venture? Apologies if old news. Just spotted the article on the Google share price website.


Two major contracts for Northern Powerhouse Funds – SAT Press Releases

These two new funds will play a leading role in the development of innovative small businesses located in the North of England. The Group is well placed to manage these new mandates having already delivered several notable successes for similar public and private funds, including Blue Prism Group PLC, Optibiotix Health PLC, Xeros Technology Group plc and Concepta PLC. We are looking forward to working with the BBB on the successful delivery of these new mandates over the coming years.



hxxp://www.satprnews.com/2017/02/22/two-major-contracts-for-northern-powerhouse-funds/

[colinzeal] 22/2/2017 09:32

I think the market is just growing tired of the expected announcements only to be met with wishy-washy RNS's every so often.

People invest when news is tipped to come soon then pull out and invest elsewhere when it doesn't come.

This is a hot sector and great company but I think people should extend their timescale somewhat.

[scotty1] 22/2/2017 09:26

The expected news is not due until spring as far as i am aware,the reason the share price as been weak these past weeks is because of selling when it got to the 80p mark (the peak)those people and the likes of you (nothing wrong with that)but then as the share price moves down you get a few of the panic sellers or "noobs" as i like to call them which keeps the share price falling.But what gets me as i said is when it gets to the peak around 80p you sell your trading stock (nothing wrong with that a profit is a profit)but then post this wont hold without news etc etc or something to the likes of that.